Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Rivus Pharmaceuticals, Inc.

News headline image
Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions
From Rivus Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH
From Rivus Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer
From Rivus Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
From Rivus Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weight Loss in Obesity at ObesityWeek®
From Rivus Pharmaceuticals, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.